Limited Sampling Strategies for Estimating Cyclosporin Area Under the Concentration–Time Curve: Review of Current Algorithms
- 1 April 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 23 (2) , 100-114
- https://doi.org/10.1097/00007691-200104000-00003
Abstract
Cyclosporin, the drug of first choice in transplantation surgery, is characterized by a low therapeutic index and variable absorption, so close monitoring of the drug is required to optimize the dosing. Predose blood cyclosporin levels are measured routinely for therapeutic monitoring, but this approach is not optimal because the area under the concentration–time curve (AUC) correlates better with clinical events. However, conventional methods of measuring AUC require many blood samples, which is not viable in a routine clinical setting. AUC monitoring can be simplified for use in a clinical setting by using a limited sampling strategy (LSS) that allows AUC to be estimated using a small number of blood samples collected at specific times. This article reviews the current literature on estimating cyclosporin AUC using LSS. Thirty-eight papers suggesting the use of specific time points were found. LSS has been developed for different transplant types, with different dosing regimens, and with different assays. Most authors suggested either two-or three-sample equations. Results from authors who validated their models suggest that equations defined on one transplant type may be applicable to other transplant types, to both adults and children, and to early or late after transplantation. Moreover, it seems that there is flexibility in the choice of equations available to clinicians. The number of samples to collect for accurate estimations is a matter of debate, but a wise choice can minimize the number. The choice of the optimal LSS and validation are discussed.Keywords
This publication has 80 references indexed in Scilit:
- Impact of early cyclosporin average blood concentration on early kidney transplant failureTransplant International, 1998
- Cyclosporin MicroemulsionBioDrugs, 1997
- Cyclosporine Pharmacokinetics and Risk of Recurrent Rejection in Recipients of Simultaneous Pancreas/Kidney TransplantsTherapeutic Drug Monitoring, 1996
- Do cyclosporin proffles provide useful information in the management of renal transplant recipients?Nephrology Dialysis Transplantation, 1996
- Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve MonitoringTherapeutic Drug Monitoring, 1995
- Prediction of Acute Graft Rejection in Renal Transplantation: The Utility of Cyclosporine Blood ConcentrationsPharmaceutical Research, 1991
- Cyclosporine Monitoring in Renal TransplantationTherapeutic Drug Monitoring, 1989
- OPTIMIZATION OF CYCLOSPORINE THERAPY IN RENAL TRANSPLANTATION BY A PHARMACOKINETIC STRATEGYTransplantation, 1988
- THE RELATIONSHIP BETWEEN CYCLOSPORINE PHARMACOKINETIC PARAMETERS AND SUBSEQUENT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1988
- CYCLOSPORIN BLOOD LEVELS DO CORRELATE WITH CLINICAL COMPLICATIONSThe Lancet, 1984